Elizabeth A Rondini, Zofia Duniec-Dmuchowski, Thomas A Kocarek
Index: Drug Metab. Dispos. 44 , 595-604, (2016)
Full Text: HTML
Our laboratory previously reported that accumulation of nonsterol isoprenoids following treatment with the squalene synthase inhibitor, squalestatin 1 (SQ1) markedly induced cytochrome P450 (CYP)2B1 mRNA and reporter activity in primary cultured rat hepatocytes, which was dependent on activation of the constitutive androstane receptor (CAR). The objective of the current study was to evaluate whether isoprenoids likewise activate murine CAR (mCAR) or one or more isoforms of human CAR (hCAR) produced by alternative splicing (SPTV, hCAR2; APYLT, hCAR3). We found that SQ1 significantly induced Cyp2b10 mRNA (∼3.5-fold) in primary hepatocytes isolated from both CAR-wild-type and humanized CAR transgenic mice, whereas the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitor pravastatin had no effect. In the absence of CAR, basal Cyp2b10 mRNA levels were reduced by 28-fold and the effect of SQ1 on Cyp2b10 induction was attenuated. Cotransfection with an expression plasmid for hCAR1, but not hCAR2 or hCAR3, mediated SQ1-induced CYP2B1 and CYP2B6 reporter activation in hepatocytes isolated from CAR-knockout mice. This effect was also observed following treatment with the isoprenoid trans,trans-farnesol. The direct agonist CITCO increased interaction of hCAR1, hCAR2, and hCAR3 with steroid receptor coactivator-1. However, no significant effect on coactivator recruitment was observed with SQ1, suggesting an indirect activation mechanism. Further results from an in vitro ligand binding assay demonstrated that neither farnesol nor other isoprenoids are direct ligands for hCAR1. Collectively, our findings demonstrate that SQ1 activates CYP2B transcriptional responses through farnesol metabolism in an hCAR1-dependent manner. Further, this effect probably occurs through an indirect mechanism. Copyright © 2016 by The American Society for Pharmacology and Experimental Therapeutics.
| Structure | Name/CAS No. | Molecular Formula | Articles |
|---|---|---|---|
![]() |
CITCO
CAS:338404-52-7 |
C19H12Cl3N3OS | |
![]() |
TCPOBOP
CAS:76150-91-9 |
C16H8Cl4N2O2 |
|
Evaluation of the HC-04 cell line as an in vitro model for m...
2014-07-01 [Drug Metab. Dispos. 42(7) , 1191-201, (2014)] |
|
Involvement of CAR and PXR in the transcriptional regulation...
2015-01-01 [Xenobiotica 45 , 773-81, (2015)] |
|
Quantitative high-throughput identification of drugs as modu...
2015-01-01 [Sci. Rep. 5 , 10405, (2015)] |
|
Chrysin, baicalein and galangin are indirect activators of t...
2015-03-04 [Toxicol. Lett. 233(2) , 68-77, (2015)] |
|
Dose-dependent induction of signaling pathways by the flavon...
2015-06-01 [Mol. Nutr. Food. Res. 59 , 1117-29, (2015)] |
Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer
Copyright © 2026 ChemSrc All Rights Reserved

